- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02684513
Impact of Oral Carbohydrate Consumption Prior to Cesarean Section
Impact of Oral Carbohydrate Consumption Prior to Cesarean Section on Preoperative Well-being
For more than 15 years, traditional fasting regimens prior to scheduled surgeries have been called into question, yet prolonged preoperative fasting remains common practice. While prolonged fasting is aimed at reducing the risk of pulmonary aspiration, prolonged fasting is uncomfortable, has an inconsistent effect on gastric volumes and acidity and may lead to dehydration without a clear reduction in the incidence of aspiration. Fasting by itself decreases hepatic glycogen stores, induces a state of insulin resistance and impairs cardiovascular function. Yet, prolonged preoperative fasting remains common.
Preoperative oral carbohydrate (CHO) consumption improves insulin sensitivity and decreases the time to return of gut function without increasing gastric volumes or acidity compared to other clear liquids and fasting. Previous work has shown oral CHO consumption improves patient well-being to a greater degree than placebo drink (water or flavored water) and fasted controls. Oral CHO also outperforms a similar volume of intravenous glucose supplementation. These benefits have reduced hospital stays in a variety of surgical models by as much as 20%. Further, preoperative CHO supplementation improved postoperative patient hunger, thirst, anxiety, fatigue and nausea.
The purpose of this research study is to determine if drinking a high carbohydrate beverage before cesarean section surgery can improve patient well-being, compared to patients who drink a low carbohydrate beverage or fast before surgery.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The study hopes to determine if either of two different oral beverages (a higher CHO concentration versus a lower CHO concentration) is superior to routine fasting in terms of preoperative well-being among patients presenting for scheduled cesarean section. Preoperative well-being will be determined by a composite of visual analog scale scores aimed at assessing hunger, thirst, anxiety, fatigue and nausea on the morning of surgery.
Women will be recruited from one of two outpatient obstetric clinics, University of Florida (UF) Health Women's Center - Medical Plaza or UF Health Women's Center. Women presenting for scheduled cesarean section will be provided with an opportunity to participate. Then the women will be randomized into one of three groups: oral carbohydrate beverage (group CHO), re-hydration beverage of an equal volume (group R) or fasted controls (group F). All subjects who consent to participation will have the following recorded: height, weight, age, indication for cesarean section, surgeon, and number of prior cesarean sections.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Florida
-
Gainesville, Florida, United States, 32610-3003
- UF Health
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Full-term (≥37 weeks gestation) with singleton gestation
- Proficient with English language
- Planning on undergoing scheduled cesarean delivery under neuraxial anesthesia
Exclusion Criteria:
- Women with pre-gestational or gestational diabetes mellitus or diabetes present prior to pregnancy
- Women who did not complete a gestational diabetes screening test
- Women who received steroids within the past 7 days prior to delivery
- Women who received magnesium sulfate in the setting of hypertensive disorders of pregnancy
- Women with a history of chronic opioid use
- Preterm pregnancies
- Fetuses with congenital abnormalities or growth restriction
- Multiple gestation
- Women who are American Society of Anesthesiology Class III or higher
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Health Services Research
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: Oral Carbohydrate Beverage Group
Subjects assigned to this group will receive 710 mL of a preoperative beverage the evening prior to surgery and 355 mL the morning of surgery.
|
The oral carbohydrate beverage will be consume in a 710 mL amount the evening prior to surgery and then a 355 mL amount the morning of surgery.
Other Names:
|
Active Comparator: Rehydration Beverage Group
Subjects assigned to this group will receive 710 mL of re-hydration beverage the evening prior to surgery and 355 mL the morning of surgery.
|
The rehydration beverage group will be consume in a 710 mL amount the evening prior to surgery and then a 355 mL amount the morning of surgery.
Other Names:
|
No Intervention: Fasted Controls
Subjects assigned to this group will fast for ≥8 hours prior to surgery.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in preoperative well-being assessment from baseline to one hour using the 100 millimeter (mm) visual analogue scale.
Time Frame: Change from baseline to one hour
|
100 mm visual analogue scales for hunger, thirst, anxiety, fatigue and nausea administered on the morning of surgery prior to morning beverage consumption and 60 minutes after the beverage.
All measurements will be assessed using the same scale starting at 0 to 100mm with 0 being the worst and 100 being the best and average being 85.
|
Change from baseline to one hour
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Changes between the maternal groups assessed by the mean arterial pressure (MAP) recordings in every 5 minute period
Time Frame: At time of surgery to the conclusion
|
Maternal cardiovascular function will be assessed by using the average of all the mean arterial pressure (MAP) recordings in every 5 minute period.
This will be measured by using a student's t-test for significant differences between the groups.
|
At time of surgery to the conclusion
|
Number of participants admitted to maternal intensive care unit between the groups
Time Frame: Up to 15 days
|
Number of ICU admissions during hospitalization between the groups
|
Up to 15 days
|
Number of days in the hospital for each participant between the groups
Time Frame: Up to 15 days
|
Number of days in the hospital for each participant between the groups.
This will be measured by using the chi-square tests to assess the frequency of this outcome between the groups.
|
Up to 15 days
|
Number of postoperative infections between the groups
Time Frame: Up to 15 days
|
Number of postoperative infections for each participant between the groups.
This will be measured by using the chi-square tests to assess the frequency of this outcome between the groups.
|
Up to 15 days
|
Neonates with plasma glucose level of less than 45 mg/dL between the groups
Time Frame: Baseline
|
First umbilical cord blood sample will be taken for plasma glucose level of less than 45 mg/dL to note hypoglycemia between the groups.
|
Baseline
|
Number of neonates with a 5 minute Apgar score less than 7 between the groups
Time Frame: 5 minutes
|
Record of the 5 minute apgar score < 7. Apgar scores are as follows: between 7 and 10, means the neonate is in good shape, between 4 and 6 may need some help breathing, and 3 or less may need immediate lifesaving measures.
|
5 minutes
|
Number of neonates on ventilation for 6 hours or greater between the groups
Time Frame: 6 hours
|
Number of neonates on ventilation for 6 hours or greater will be recorded.
|
6 hours
|
Number of neonates diagnosed with an infection between the groups.
Time Frame: Baseline
|
Number of neonates with an infection diagnosis.
This will be measured by using the chi-square tests to assess the frequency of this outcome between the groups.
|
Baseline
|
Number of neonates admitted to the intensive care unit (ICU) between the groups
Time Frame: Baseline
|
Number of neonates admitted to the ICU between the groups.
This will be measured by using the chi-square tests to assess the frequency of this outcome between the groups.
|
Baseline
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Adam Wendling, MD, University of Florida
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201501150
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dehydration
-
United States Army Research Institute of Environmental...CompletedDehydration Hypertonic | Isotonic Dehydration
-
University of HartfordArizona State University; Kraft Heinz CompanyRecruitingDehydration in Children | Dehydration Following Exertion (Disorder)United States
-
Fondazione IRCCS Ca' Granda, Ospedale Maggiore...UnknownAged | Dehydration HypertonicItaly
-
University of DelawareNational Heart, Lung, and Blood Institute (NHLBI); National Institute of General...Completed
-
Rhode Island HospitalInternational Centre for Diarrhoeal Disease Research, Bangladesh; Fogarty International...Completed
-
Wayne State UniversityUniversity of ChicagoUnknown
-
University College, LondonUniversity of Portsmouth; University of WollongongUnknownDehydration HypertonicUnited Kingdom
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker CochinRecruitingMild to Moderate DehydrationFrance
-
Cedars-Sinai Medical CenterTerminatedDehydration, Diverting Ileostomy, LoperamideUnited States
-
University of Illinois at ChicagoAbbott NutritionCompleted
Clinical Trials on Oral Carbohydrate Beverage
-
Yonsei UniversityUnknown
-
Yonsei UniversityCompletedColorectal DiseaseKorea, Republic of
-
Old Dominion UniversityRecruitingAnomalies GastrointestinalUnited States
-
Old Dominion UniversityCompletedImpaired ThermoregulationUnited States
-
Kangbuk Samsung HospitalCompleted
-
University of Colorado, Colorado SpringsNot yet recruitingMenstrual Irregularity
-
University of Texas at AustinDairy Research InstituteCompletedOral Glucose Tolerance Test | High Fat Tolerance TestUnited States
-
Appalachian State UniversityDole Food CompanyCompleted
-
USDA Beltsville Human Nutrition Research CenterUnited States Army Research Institute of Environmental MedicineCompletedHealthy VolunteersUnited States
-
Uppsala UniversityKarolinska InstitutetCompletedHip Fracture | Gastroparesis | Mild Insufficient Nutrition